Dr Rui Pedro Galão Academics Supervisors Senior Lecturer in Infectious Diseases Research subject areas Immunology Contact details rui_pedro.galao@kcl.ac.uk +44 (0) 20 7848 2610
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency Kcl Test: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance. TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a laboratory evaluation study More than the eye can see – shedding new light on SARS-CoV-2 Lateral Flow Device-based immunoassays Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19 Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2 Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides Retroviral retention activates a Syk-dependent HemITAM in human tetherin Evidence for IFNalpha-induced, SAMHD1-independent inhibitors of early HIV-1 infection Innate Sensing of HIV-1 Assembly by Tetherin Induces NFκB-Dependent Proinflammatory Responses Release of filamentous and spherical influenza A virus is not restricted by tetherin Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors View all publications